483
InnoStar Bio-Tech Nantong Company, Ltd.InnoStar Bio-Tech Nantong Company, Ltd. – FDA 483, Nov 1, 2024
Record Details
An FDA inspection of InnoStar Bio-Tech Nantong Co. Ltd., a nonclinical laboratory in Nantong City, China, revealed significant deficiencies. The firm was cited for inadequate written standard operating procedures that compromised data quality and integrity, and for failing to retain reserve samples of test articles for long-duration studies. These issues indicate a lack of control over critical study processes and regulatory compliance.
View Company Profile
ID · 00d3ba19-603d-468f-8d42-04a1a23d372d
Other documents for InnoStar Bio-Tech Nantong Company, Ltd.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.